Cutter Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-658,409	Closed	-$12.2M	–	27
2024 Q1	$12.2M	Buy	658,409 +327,436	+99%	+$6.05M	4.66%	9
2023 Q4	$10.4M	Buy	+330,973	New	+$10.4M	4.95%	10